- Corporate Officers - R
- Ratcliffe Liam
Insider Trading History of Ratcliffe Liam
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ratcliffe Liam since 2013.
This trader's CIK number is 1547100.
At the time of last reporting, Ratcliffe Liam was the Director of Arvinas, Inc.. (stock ticker symbol ARVN).
Also see all insider trading activities at Arvinas, Inc..
Note that in the past
Ratcliffe Liam also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Relypsa Inc (RLYP) by Ratcliffe Liam
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2013 | RLYP | 185,978 | $2,045,758 | 0 | $0 | 25,977 | $238,598 |
Yearly summary of insider trading at Iterum Therapeutics Plc (ITRM) by Ratcliffe Liam
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | ITRM | 662,677 | $8,614,801 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Pds Biotechnology Corp (EDGE) by Ratcliffe Liam
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | EDGE | 0 | $0 | 0 | $0 | 10,000 | $0 |
Yearly summary of insider trading at Deciphera Pharmaceuticals, Inc. (DCPH) by Ratcliffe Liam
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | DCPH | 375,000 | $6,375,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Cogent Biosciences, Inc. (UMRX) by Ratcliffe Liam
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | UMRX | 550,000 | $6,600,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aravive, Inc. (VSAR) by Ratcliffe Liam
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2014 | VSAR | 60,000 | $1,261,200 | 962,556 | $18,599,133 | 0 | $0 |
Yearly summary of insider trading at Passage Bio, Inc. (PASG) by Ratcliffe Liam
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | PASG | 2,800 | $50,400 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aptinyx Inc. (APTX) by Ratcliffe Liam
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | APTX | 250,000 | $4,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Array Biopharma Inc (ARRY) by Ratcliffe Liam
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2013 | ARRY | 0 | $0 | 3,376,186 | $20,260,308 | 0 | $0 |
Yearly summary of insider trading at Arvinas, Inc. (ARVN) by Ratcliffe Liam
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | ARVN | 0 | $0 | 662,094 | $51,167,355 | 18,423 | $512,435 |
2020 | ARVN | 142,857 | $9,999,990 | 0 | $0 | 6,500 | $143,390 |
2019 | ARVN | 680,000 | $14,960,000 | 0 | $0 | 0 | $0 |
2018 | ARVN | 1,000,000 | $16,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Mei Pharma, Inc. (MEIP) by Ratcliffe Liam
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | MEIP | 0 | $0 | 1,601,390 | $3,159,542 | 0 | $0 |
2014 | MEIP | 0 | $0 | 79,085 | $475,608 | 0 | $0 |
2013 | MEIP | 0 | $0 | 365,000 | $3,011,250 | 0 | $0 |
Insider trading activities at 11 companies by Ratcliffe Liam:
1. Relypsa Inc (RLYP)
2. Iterum Therapeutics Plc (ITRM)
3. Pds Biotechnology Corp (EDGE)
4. Deciphera Pharmaceuticals, Inc. (DCPH)
5. Cogent Biosciences, Inc. (UMRX)
6. Aravive, Inc. (VSAR)
7. Passage Bio, Inc. (PASG)
8. Aptinyx Inc. (APTX)
9. Array Biopharma Inc (ARRY)
10. Arvinas, Inc. (ARVN)
11. Mei Pharma, Inc. (MEIP)
Table 1. Insider trading of Relypsa Inc (RLYP) by Ratcliffe Liam
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2013-11-20 | RLYP | Option Ex | 25,977 | 9.19 | 238,598 |
2013-11-20 | RLYP | Buy | 185,978 | 11.00 | 2,045,758 |
Table 2. Insider trading of Iterum Therapeutics Plc (ITRM) by Ratcliffe Liam
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-05-30 | ITRM | Buy | 662,677 | 13.00 | 8,614,801 |
Table 3. Insider trading of Pds Biotechnology Corp (EDGE) by Ratcliffe Liam
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-03-15 | EDGE | Option Ex | 10,000 | .00 | 0 |
Table 4. Insider trading of Deciphera Pharmaceuticals, Inc. (DCPH) by Ratcliffe Liam
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-10-02 | DCPH | Buy | 375,000 | 17.00 | 6,375,000 |
Table 5. Insider trading of Cogent Biosciences, Inc. (UMRX) by Ratcliffe Liam
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-04-03 | UMRX | Buy | 550,000 | 12.00 | 6,600,000 |
Table 6. Insider trading of Aravive, Inc. (VSAR) by Ratcliffe Liam
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2014-12-18 | VSAR | Sale | 150,000 | 19.01 | 2,851,800 |
2014-11-11 | VSAR | Sale | 800,000 | 19.37 | 15,496,000 |
2014-09-29 | VSAR | Sale | 12,556 | 20.02 | 251,333 |
2014-03-27 | VSAR | Buy | 60,000 | 21.02 | 1,261,200 |
Table 7. Insider trading of Passage Bio, Inc. (PASG) by Ratcliffe Liam
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-03-03 | PASG | Buy | 2,800 | 18.00 | 50,400 |
Table 8. Insider trading of Aptinyx Inc. (APTX) by Ratcliffe Liam
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-06-25 | APTX | Buy | 250,000 | 16.00 | 4,000,000 |
Table 9. Insider trading of Array Biopharma Inc (ARRY) by Ratcliffe Liam
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2013-09-26 | ARRY | Sale | 262,207 | 6.02 | 1,579,010 |
2013-09-27 | ARRY | Sale | 863,521 | 5.99 | 5,170,763 |
2013-09-12 | ARRY | Sale | 807,479 | 6.10 | 4,923,199 |
2013-09-13 | ARRY | Sale | 546,660 | 6.01 | 3,287,613 |
2013-09-16 | ARRY | Sale | 319,033 | 6.14 | 1,957,586 |
2013-09-04 | ARRY | Sale | 236,116 | 5.87 | 1,385,528 |
2013-09-05 | ARRY | Sale | 201,598 | 5.77 | 1,163,422 |
2013-09-06 | ARRY | Sale | 139,572 | 5.68 | 793,187 |
Table 10. Insider trading of Arvinas, Inc. (ARVN) by Ratcliffe Liam
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-12-14 | ARVN | Sale | 156,464 | 65.20 | 10,201,139 |
2021-12-15 | ARVN | Sale | 113,536 | 66.57 | 7,557,864 |
2021-12-16 | ARVN | Sale | 85,705 | 69.31 | 5,940,556 |
2021-11-15 | ARVN | Sale | 21,284 | 84.49 | 1,798,200 |
2021-11-10 | ARVN | Sale | 13,358 | 88.23 | 1,178,603 |
2021-11-11 | ARVN | Sale | 59,799 | 86.67 | 5,182,898 |
2021-11-12 | ARVN | Sale | 39,869 | 84.76 | 3,379,455 |
2021-11-09 | ARVN | Sale | 33,008 | 91.97 | 3,035,646 |
2021-11-08 | ARVN | Sale | 81,054 | 93.66 | 7,591,517 |
2021-11-05 | ARVN | Sale | 58,017 | 91.38 | 5,301,477 |
2021-11-05 | ARVN | Option Ex | 18,423 | 27.82 | 512,435 |
2020-12-18 | ARVN | Buy | 142,857 | 70.00 | 9,999,990 |
2020-05-26 | ARVN | Option Ex | 6,500 | 22.06 | 143,390 |
2019-11-12 | ARVN | Buy | 680,000 | 22.00 | 14,960,000 |
2018-10-01 | ARVN | Buy | 1,000,000 | 16.00 | 16,000,000 |
Table 11. Insider trading of Mei Pharma, Inc. (MEIP) by Ratcliffe Liam
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-03-24 | MEIP | Sale | 1,601,390 | 1.97 | 3,159,542 |
2014-12-08 | MEIP | Sale | 9,004 | 6.05 | 54,492 |
2014-12-09 | MEIP | Sale | 70,081 | 6.01 | 421,116 |
2013-11-21 | MEIP | Sale | 365,000 | 8.25 | 3,011,250 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Ratcliffe Liam
(Director of Arvinas, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.